| DRUGS INDEX | MANUFACTURERS INDEX | HEALTH | ANATOMY | GEOGRAPHY | USA STATISTICS | CHINA STATISTICS | JOBS |

PrimaCare One Capsules (Ther-Rx)

Custom Search
  • Description
  • Indications and Usage
  • Contraindications
  • Warnings
  • Precautions
  • Adverse Reactions
  • Dosage and Administration
  • How Supplied

    - Drugs index
    - Manufacturers
    - Feedback

  • DESCRIPTION

    PrimaCare® ONE is a prescription prenatal/postnatal multivitamin/mineral capsule with Essential Fatty Acids. Each purple soft gelatin capsule contains:

    OmegaNate™ Essential Fatty Acids and Precursors:
    Omega-3 Fatty Acids 300 mg
    Linoleic Acid 30 mg
    Linolenic Acid   30 mg

    Vitamins:
    Folic Acid, USP   1 mg
    Vitamin B 6 (as pyridoxine HCl) 25 mg
    Vitamin C (as Ester-C ®) * 25 mg
      Vitamin D 3 (from cholecalciferol) 170 IU
    Vitamin E (from dl-alpha-tocopheryl acetate) 30 IU

    Minerals:
    Calcium 150 mg
    Iron (as carbonyl iron)  27 mg
    * Ester-C ® is a patented pharmaceutical grade material consisting of calcium ascorbate and calcium threonate. Ester-C ® is a licensed trademark of Zila Nutraceuticals, Inc.


    Inactive Ingredients:    Gelatin, vegetable shortening, glycerine, soybean oil, yellow beeswax, lecithin, titanium dioxide, methylparaben, ethylvanillin, D&C Red #33, propylparaben, FD&C Blue #1.

    INDICATIONS

    PrimaCare® ONE is indicated to provide vitamin/mineral and essential fatty acid supplementation throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. It is also useful for improving nutritional status prior to conception.

    CONTRAINDICATIONS

    This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

    WARNING

    Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B 12 is deficient.

    WARNING:    Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

    PRECAUTIONS

    Folic acid in doses above 1.0 mg daily may obscure perni-cious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.

    PEDIATRIC USE

    Safety and effectiveness in pediatric patients has not been established.

    GERIATRIC USE

    Clinical studies on this product have not been performed to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for elderly patients should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

    ADVERSE REACTIONS

    Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

    DOSAGE AND ADMINISTRATION

    Usual dosage is one capsule daily, or as prescribed by a physician.

    HOW SUPPLIED

    PrimaCare® ONE prenatal/postnatal multivitamin/mineral capsules with essential fatty acids for oral administration are supplied as purple soft gelatin capsules imprinted "Ther-Rx 142" in white ink in bottles of 30 soft gelatin capsules (NDC 64011-142-19). Store at controlled room temperature 15°-30° C (59°-86° F).

    KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.

    P4350 11/03

    Mktd. by Ther-Rx Corp.

    St. Louis, MO 63044

    U.S. Patent Nos.: 4,822,816; 5,070,085; 6,197,329; 6,258,846; 6,569,857; 6,576,666.

    Other U.S. Patents Pending













    - To bookmark this page (add it to your favorites), please click the image to the left.
    - If you wish to link to this page, you can do so by referring to the URL address below this line.

    https://theodora.com/drugs/primacare_one_capsules_ther_rx.html

    This page was last modified 30-JUN-07
    Copyright © 1995-2007 ITA all rights reserved.
    CTR070611